Ketamine for Refractory Headache: A Retrospective Analysis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: The burden of chronic headache disorders in the United States is substantial. Some patients are treatment refractory. Ketamine, an N-methyl-D-aspartate antagonist, provides potent analgesia in subanesthetic doses in chronic pain, and limited data suggest it may alleviate headache in some patients. METHODS: We performed a retrospective study of 61 patients admitted over 3 years for 5 days of intravenous therapy that included continuous ketamine to determine responder rate and patient and ketamine infusion characteristics. Pain ratings at 2 follow-up visits were recorded. An immediate responder was a patient with decrease of 2 points or greater in the numerical rating scale (0-10) from start to final pain in the hospital. Sustained response at office visits 1 and 2 was determined based on maintaining the 2-point improvement at those visits. Patients were assessed daily for pain and adverse events (AEs). RESULTS: Forty-eight (77%) of the 61 patients were immediate responders. There were no differences regarding demographics, opioid use, or fibromyalgia between immediate responders and nonresponders. Maximum improvement occurred 4.56 days (mean) into treatment. Sustained response occurred in 40% of patients at visit 1 (mean, 38.1 days) and 39% of patients at visit 2 (mean, 101.3 days). The mean maximum ketamine rate was 65.2 ± 2.8 mg/h (0.76 mg/kg per hour). Ketamine rates did not differ between groups. Adverse events occurred equally in responders and nonresponders and were mild. CONCLUSIONS: Ketamine was associated with short-term analgesia in many refractory headache patients with tolerable adverse events. A prospective study is warranted to confirm this and elucidate responder characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buse, D. C., Manack, A. N., Fanning, K. M., Serrano, D., Reed, M. L., Turkel, C. C., & Lipton, R. B. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02223.x · Cited by 549 · cited 1×
“Subanesthetic ketamine may also be effective for short-term relief of chronic migraine and other refractory headache disorders,(2,3) which affect up to 2% of the population of the United States, inflicting a major clinical and financial burden on patients and the health care system.(4) The mechanism by which ketamine…”
BackgroundZarate, C. A., Brutsche, N., Laje, G., Luckenbaugh, D. A., Venkata, S. L. V., Ramamoorthy, A., Moaddel, R., & Wainer, I. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.004 · Cited by 282
Cited by
Orhurhu, V., Orhurhu, M. S., Bhatia, A., & Cohen, S. P. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004185 · Cited by 179
Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis
Schwenk, E. S., Torjman, M. C., Moaddel, R., Lovett, J., Katz, D., Denk, W., Lauritsen, C., Silberstein, S. D., & Wainer, I. W. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1920 · Cited by 20
Self-citationChah, N., Jones, M., Milord, S., Al-Eryani, K., & Enciso, R. (2021) · Journal of Dental Anesthesia and Pain Medicine · doi:10.17245/jdapm.2021.21.5.413 · Cited by 19
“It should be noted that in three retrospective studies on chronic refractory migraines and new daily persistent headaches, positive results were shown in those cohorts of patients using ketamine infusions [18,27,40].”
ResultReal-world study of intranasal ketamine for use in patients with refractory chronic migraine
Yuan, H., Natekar, A., Park, J. S., Lauritsen, C., Viscusi, E. R., & Marmura, M. J. (2022) · doi:10.1101/2022.11.20.22282558 · Cited by 1
Self-citation
Metadata
- Authors
- Schwenk, E. S., Dayan, A. C., Rangavajjula, A., Torjman, M. C., Hernandez, M. G., Lauritsen, C. G., Silberstein, S. D., Young, W., & Viscusi, E. R.
- Venue
- Regional Anesthesia and Pain Medicine
- Publisher
- BMJ
- Published
- 2018-06
- Volume
- 43
- Issue
- 8
- Pages
- 1
- ISSN
- 1098-7339 (ISSN-L)
- OpenAlex
- W2808859027
- Cited by
- 23
- References
- 2
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine for Refractory Headache: A Retrospective Analysis. https://app.cochat.ai/papers/10.1097/aap.0000000000000827
- The paper
- Schwenk, E. S., Dayan, A. C., Rangavajjula, A., Torjman, M. C., Hernandez, M. G., Lauritsen, C. G., Silberstein, S. D., Young, W., & Viscusi, E. R. (2018). Ketamine for Refractory Headache: A Retrospective Analysis. Regional Anesthesia and Pain Medicine. https://doi.org/10.1097/aap.0000000000000827
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.